RGS6 and neoplasm: Using RGS6−/− mice, we provide the first evidence that RGS6 loss accelerates BBN-induced UBC progression; and that p53 activation with CP-31398 [24], and/or DNMT1 inhibition with 5-Aza prevents tumor formation.